Результаты поиска - C. Chouaïd

Отмена результатов
  1. 1
    Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review

    Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review по Kokuvi Atsou, C. Chouaïd, Gilles Hejblum

    Опубликовано 2011
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  2. 2
    ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date

    ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date по S. Gendarme, Olivier Bylicki, C. Chouaïd, Florian Guisier

    Опубликовано 2022
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  3. 3
    Papillon trial, a major advance in the management of patients with metastatic, mutated-EGFR exon 20 insertion non-small-cell lung cancer

    Papillon trial, a major advance in the management of patients with metastatic, mutated-EGFR exon 20 insertion non-small-cell lung cancer по C. Chouaïd, Jean‐Baptiste Assié, J.B. Auliac

    Опубликовано 2025
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Delays for diagnosis and treatment of lung cancers: a systematic review

    Delays for diagnosis and treatment of lung cancers: a systematic review по F. Viñas, I. Ben Hassen, L. Jabot, I. Monnet, C. Chouaïd

    Опубликовано 2014
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  5. 5
    Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care

    Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care по Olivier Bylicki, Morgane Didier, F. Rivière, J. Margery, F. Grassin, C. Chouaïd

    Опубликовано 2019
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  6. 6
    Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study

    Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study по Laurent Laforest, Nicolás Roche, Gilles Devouassoux, Manon Belhassen, C. Chouaïd, M. Ginoux, Éric Van Ganse

    Опубликовано 2016
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    Lung cancer and interstitial lung disease: a literature review

    Lung cancer and interstitial lung disease: a literature review по Jean‐Marc Naccache, Q. Gibiot, I. Monnet, Martine Antoine, Marie Wislez, C. Chouaïd, Jacques Cadranel

    Опубликовано 2018
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  8. 8
    Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France

    Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-smal... по C. Chouaïd, L. Bensimon, E. Clay, A. Millier, L. Lévy-Bachelot, Min Huang, Pierre Lévy

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection

    Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection по Joël Gozlan, J.‐M. Salord, C. Chouaïd, Claudine Duvivier, O Picard, Marie‐Caroline Meyohas, Jean‐Claude Petit

    Опубликовано 1993
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    Chronic bronchitis in the general population: Influence of age, gender and socio-economic conditions

    Chronic bronchitis in the general population: Influence of age, gender and socio-economic conditions по Alexis Ferré, C. Fuhrman, Mahmoud Zureik, C. Chouaïd, A. Vergnenègre, Gérard Huchon, Marie-Christine Delmas, Nicolás Roche

    Опубликовано 2011
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials

    Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials по Thierry Landre, G. Justeau, Jean‐Baptiste Assié, Kader Chouahnia, Claire Davoine, Chérifa Taleb, C. Chouaïd, Boris Duchemann

    Опубликовано 2021
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  12. 12
    Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment

    Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment по H. Picchi, Christine Mateus, C. Chouaïd, Benjamin Besse, Aurélien Marabelle, Jean‐Marie Michot, Stéphane Champiat, Anne-Laure Voisin, Olivier Lambotte

    Опубликовано 2017
    Полный текст Полный текст
    Editorial
    Добавить в Избранное
    Сохранить в:
  13. 13
    The association between asthma control, health care costs, and quality of life in France and Spain

    The association between asthma control, health care costs, and quality of life in France and Spain по Marianne Doz, C. Chouaïd, Laure Com-Ruelle, Eduardo Calvo, Max Brosa, J. Robert, L. Decuypère, C. Pribil, Alicia Huerta, B. Detournay

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis

    Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis по Thierry Landre, Abdoulaye Karaboué, Zachary S. Buchwald, Pasquale F. Innominato, David C. Qian, Jean‐Baptiste Assié, C. Chouaïd, Françis Lévi, Boris Duchemann

    Опубликовано 2024
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  15. 15
    Preclinical and Preliminary Clinical Activity of NVP-BKM120, an Oral Pan-Class I PI3K Inhibitor, in the Brain

    Preclinical and Preliminary Clinical Activity of NVP-BKM120, an Oral Pan-Class I PI3K Inhibitor, in the Brain по Michel Maira, Christian Schnell, Pier‐Luigi Lollini, C. Chouaïd, Peter Schmid, Paolo Nanni, Dawn Lam, Emmanuelle di Tomaso, Cristian Massacesi, Jordi Rodón

    Опубликовано 2012
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601)

    Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601) по C. Decroisette, I. Monnet, H. Bérard, Gilles Quéré, H. Le Caer, Suzanna Bota, Clarisse Audigier-Valette, L. Gérinière, Jean-Marc Vernejoux, C. Chouaïd

    Опубликовано 2011
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study

    Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study по J. Le Treut, M. C. Sault, H. Léna, P.-J. Souquet, A. Vergnenègre, H. Le Caer, H. Bérard, S. Boffa, I. Monnet, Diane Damotte, C. Chouaïd

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC

    Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC по Paul Lesueur, Alexandre Escande, Juliette Thariat, E. Vauléon, I. Monnet, Alexis B. Cortot, D. Lerouge, S. Danhier, Pascal Dô, Catherine Dubos‐Arvis, C. Chouaïd, Radj Gervais

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy

    Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy по Romain-David Seban, Jean‐Baptiste Assié, Etienne Giroux‐Leprieur, Marie-Ange Massiani, G. Bonardel, C. Chouaïd, Nicolas Deleval, Capucine Richard, Laura Mezquita, Nicolas Girard, Laurence Champion

    Опубликовано 2021
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis

    Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis по Matteo Giaj Levra, François-Emery Cotté, R. Corre, C. Calvet, Anne-Françoise Gaudin, John R. Penrod, V. Grumberg, B. Jouaneton, R. Jolivel, Jean‐Baptiste Assié, C. Chouaïd

    Опубликовано 2019
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: